medicare

The U.S. Centers for Medicare & Medicaid Services (CMS) proposed rule changes for the 2027 Medicare Advantage and Part D contract year. The goal is to refine plan performance metrics and simplify enrollment. The agency said the updates will sharpen the Medicare Advantage program's value for...

Medicare's standard monthly Part B premium will jump to $202.90 in 2026, a 9.7% increase from $185 in 2025, adding to the pressure on seniors already facing rising health costs, the Centers for Medicare and Medicaid Services said. Monthly Actuarial Rates Rise Alongside Higher Deductibles In a...

Health insurance company UnitedHealth Group (NYSE:UNH) has had a rally in shares in the third quarter, helped by news of Warren Buffett taking a stake. An earnings report Tuesday before market open could continue the rally or see shares give back some gains. Here are the earnings estimates, what...

Humana Inc. (NYSE:HUM) lost a legal battle challenging cuts to its Medicare Advantage bonus payments, raising concerns over billions in potential revenue. Per a media report on Tuesday, a Texas judge ruled in favor of the federal government and upheld the downgrade of Humana's star ratings—ratings...

The Centers for Medicare & Medicaid Services (CMS) announced on Friday that Medicare Advantage (MA) and Medicare Part D prescription drug program premiums, benefits and plan options are expected to remain largely stable in 2026. Average premiums are projected to decline slightly, reinforcing...

AbbVie Inc. (NYSE:ABBV), the manufacturer of Imbruvica, is at the center of a constitutional challenge to the federal government's new Drug Price Negotiation Program. Imbruvica was among the first 10 drugs selected for price negotiations under the Inflation Reduction Act of 2022. The law gave the...

Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) stock experienced a drop of 5.54% on Thursday, followed by a remarkable recovery of 14.29% in after-hours trading. What Happened: Sonnet BioTherapeutics’ stock fell by 5% during regular trading hours on Thursday. The drop was attributed to...

Billionaire entrepreneur and Cost Plus Drugs founder Mark Cuban believes that these two changes could dramatically improve the U.S. healthcare system. What Happened: On Thursday, Cuban responded to a question about what two changes he would make to fix the U.S. healthcare system, if he had full...

Social Security and Medicare's main trust funds will be depleted in 2033, a year earlier than last forecast, trustees said Wednesday. What Happened: The annual report advanced Medicare's insolvency date by three years after higher-than-expected 2024 hospital spending and slower wage growth eroded...

In a practical guide published by Ramsey Solutions, financial expert Dave Ramsey's team tells Americans what they need to know about Medicare. What Happened: "What is Medicare and how does it work?" is a commonly asked question that reflects the anxiety many face when enrolling in Medicare. "So,...

The Trump administration has expressed its readiness to contemplate alterations to the Medicare program, contingent on the Senate’s discovery of any fraudulent activities or misuse. What Happened: White House National Economic Council director Kevin Hassett clarified the administration’...

President Donald Trump’s “big beautiful bill” has been approved by the House, marking a significant step towards its potential impact on Americans’ finances. What Happened: The bill, passed on Thursday, is a comprehensive piece of legislation that extends the...

The trading activity of members of Congress has drawn increased attention from retail traders. Some disclosed trades resulted in huge profits, potential conflicts of interest, and red flags. One new member of Congress found out that trading stocks while in office might not be as easy as everyone...

Elon Musk‘s previous comments on immigrants and entitlement programs were fact-checked by experts while also drawing a comprehensive response from an economics professor. What Happened: Musk, during an interview in March with Fox Business Network, made contentious remarks suggesting that...

The Trump Administration is reportedly mulling over a policy to match U.S. drug prices with those in other developed nations. What Happened: The Trump Administration is contemplating a policy to align U.S. drug prices with lower rates in other developed countries. The policy is likely to...